Chiattone, C.
99  results:
?
1

A PREVENÇÃO DEVE SER A MELHOR ESTRATÉGIA PARA ENFRENTAR A L..:

Chiattone, C ; Miranda, E ; Gonzaga, Y...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S90-S91 , 2022
 
?
 
?
 
?
7

6032 POSTER The immunohistochemical expression of BCL-2 to ..:

Carvalho, M. ; Chiattone, C.S.C. ; Paes, R.A.P.P...
European Journal of Cancer Supplements.  5 (2007)  4 - p. 354 , 2007
 
?
8

6023 POSTER Tissue microarrays method is useful for immunop..:

Carvalho, M. ; Chiattone, C.S.C. ; Soares, F.S..
European Journal of Cancer Supplements.  5 (2007)  4 - p. 351-352 , 2007
 
?
 
?
14

COMPARISON OF CLINICAL AND LABORATORY FEATURES, DRUG AVAILA..:

Pfister, V. ; Marques, F.M. ; Santucci, R....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 101-102 , 2020
 
?
15

CARACTERÍSTICAS CLÍNICAS E DESFECHOS DA LEUCEMIA/LINFOMA DE..:

Nogueira, D.S. ; Delamain, M.T. ; Miranda, E.C.M....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 214-215 , 2020
 
1-15